新兴趋势和单克隆抗体的治疗应用
Janaki Ramaiah Mekala1, Hari P Nalluri2, Prakash Narayana Reddy3
1Department of Biotechnology, Koneru Lakshmaiah Education Foundation (KLEF), Vaddeswaram 522502, Guntur, Andhra Pradesh, INDIA.
Gene
|May 26, 2024
概括
单克隆抗体 (mAbs) 正在彻底改变疾病治疗,提供具有较少副作用的向疗法. 抗体工程和生物仿制药方面的创新正在改善各种医疗需求的疗效和可负担性.
科学领域:
- 生物技术和制药科学 生物技术和制药科学
- 免疫学和治疗学 免疫学和治疗学
背景情况:
- 单克隆抗体 (mAbs) 在治疗恶性瘤,传染病和自身免疫性疾病方面至关重要.
- mAb市场已大幅扩大,目前有超过250种治疗性mAbs在临床试验中.
- 从小鼠抗体到人性化和完全人类抗体的进步降低了免疫性风险.
研究的目的:
- 提供关于单克隆抗体 (mAb) 生产和发展的全面概述.
- 讨论已批准的指示和mAb研究的新进展.
- 突出MABS对现代治疗的影响.
主要方法:
- 审查mAb生产技术,包括混合体技术.
- 对mAbs.的临床前和临床发展途径的分析.
- 探索抗体工程创新,如生物类似药和生物优化药.
主要成果:
- 与传统药物相比,mAbs提供向蛋白相互作用,减少不良反应和药物相互作用.
- 生物类似抗体通过降低生产成本提高了商业可行性.
- 生物更好的抗体表现出更好的疗效,解决未满足的医疗需求.
结论:
- 单克隆抗体代表了具有广泛临床应用的变革性疗法类别.
- 在mAb技术中不断的创新,包括下一代测序 (NGS),有望在临床治疗中取得进一步的进步.
- mAbs准备在广泛的疾病中彻底改变药物治疗方法.
相关概念视频
Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K


